Dose–response effect of antibodies to S100 protein and cannabinoid receptor type 1 in released-active form in the light–dark test in mice

EV Kardash, IA Ertuzun, GR Khakimova… - Dose …, 2018 - journals.sagepub.com
Earlier studies have shown that combination of antibodies to S100 protein and to
cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic …

Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB‐13, in mice

G Pryce, D Baker - British Journal of Pharmacology, 2017 - Wiley Online Library
Background and Purpose Cannabis is a recreational drug leading to intoxication, following
stimulation of cannabinoid CB1 receptors. However, more recently, herbs mixed with …

Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test

RF Genn, S Tucci, EM Marco, MP Viveros… - Pharmacology …, 2004 - Elsevier
In spite of the addictive properties of cannabinoids, under certain circumstances, they can
evoke strong anxiogenic and aversive responses in humans and in animal tests of anxiety …

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

M Rinaldi-Carmona, F Barth, J Millan, JM Derocq… - … of Pharmacology and …, 1998 - ASPET
Based on both binding and functional data, this study introduces SR 144528 as the first,
highly potent, selective and orally active antagonist for the CB2 receptor. This compound …

Behavioral effects of the novel cannabinoid full agonist AM 411

PJ McLaughlin, D Lu, KM Winston, G Thakur… - Pharmacology …, 2005 - Elsevier
AM 411 ((-)-1-adamantyl-Δ8-tetrahydrocannabinol) is a novel full agonist at cannabinoid
CB1 receptors. The present studies were conducted to provide behavioral characterization …

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A

A Perio, M Rinaldi-Carmona, J Maruani… - Behavioural …, 1996 - journals.lww.com
Active cannabimimetic drugs are known to bind to two receptor subtypes: one, called CB1, is
mainly localised in the central nervous system while the other (CB2) is expressed …

In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form

EA Gorbunov, IA Ertuzun, EV Kachaeva… - Neuropsychiatric …, 2015 - Taylor & Francis
Experimentally and clinically, it was shown that released-active form of antibodies to S100
protein (RAF of Abs to S100) exerts a wide range of pharmacological activities: anxiolytic …

Effects of acutely applied cannabinoid CB1 ligands on learning and memory in rats with a model of depression

M Marinov, M Ivanova, S Belcheva… - Compt. Rend. Acad …, 2013 - proceedings.bas.bg
The effects of cannabinoid CB1 receptor agonist HU–210 and CB1 receptor antagonist SR
141716A on learning and memory (shuttle-box) of male Wistar rats with a model of …

Expression, surface immobilization, and characterization of functional recombinant cannabinoid receptor CB2

SC Locatelli-Hoops, I Gorshkova, K Gawrisch… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Human peripheral cannabinoid receptor CB 2, a G protein-coupled receptor (GPCR)
involved in regulation of immune response has become an important target for …

[HTML][HTML] Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats

S Bilel, M Tirri, R Arfè, S Stopponi… - Frontiers in …, 2019 - frontiersin.org
AKB48 is a designer drug belonging to the indazole synthetic cannabinoids class, illegally
sold as herbal blend, incense, or research chemicals for their psychoactive cannabis-like …